The results were in concordance with those reported by Zhao et al., who found that the percentage of CD19+ mBCMA+ cells negatively correlated with the titres of anti-dsDNA antibodies and the SLEDAI, even though they reported increased BCMA expression in SLE patients32. Here, CD19 is linked to systemic lupus erythematosus.